Anthony Doyle
Chief Financial Officer at Biocryst Pharmaceuticals Inc (BCRX)
Anthony Doyle has filed 10 insider reports with the SEC since November 2021, as chief Financial Officer at Biocryst Pharmaceuticals Inc (BCRX). Anthony Doyle made no open-market purchases or sales in the last 12 months. The latest filing, on December 23, 2024, reports grant or award and shares withheld for taxes or exercise price at Biocryst Pharmaceuticals Inc (BCRX).
- Filings
- 10
- Companies
- 1
- Bought on market
- $642K
- Sold on market
- $62.1K
Companies where Anthony Doyle is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | 377,867 | $642K | $62.1K | $8.97 | $7.22-20% | Dec 23, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Dec 19, 2024BCRXChief Financial Officer Doyle Anthony was granted 120,700 shares and covered exercise/tax liability with 2,461 shares, increasing direct ownership by 46% to 377,867 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Dec 14, 2024BCRXChief Financial Officer Doyle Anthony covered exercise/tax liability with 7,890 shares, decreasing direct ownership by 3% to 259,628 unitsForm 4Shares withheld for taxes or exercise price
- May 14, 2024+$202KBCRXDoyle Anthony bought $202,191 worth of shares (36,300 units at $5.57), increasing direct ownership by 16% to 266,744 unitsForm 4Open-market purchase
- Dec 19, 2023BCRXDoyle Anthony covered exercise/tax liability with 2,482 shares, decreasing direct ownership by 1% to 227,444 unitsForm 4Shares withheld for taxes or exercise price
- Dec 14, 2023BCRXDoyle Anthony was granted 34,000 shares and covered exercise/tax liability with 5,475 shares, increasing direct ownership by 14% to 229,926 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Dec 19, 2022BCRXSEC Form 4: Doyle Anthony was granted 34,000 shares, increasing direct ownership by 21% to 197,966 unitsForm 4Grant or award
- Dec 15, 2022-$62.1KBCRXSEC Form 4: Doyle Anthony sold $62,130 worth of shares (5,700 units at $10.90) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 163,966 units (withholding obligation)Form 4Open-market sale10b5-1 plan
- Dec 14, 2021BCRXSEC Form 4: Doyle Anthony was granted 75,000 shares, increasing direct ownership by 80% to 168,719 units (Amendment)Form 4Grant or award
- Dec 14, 2021BCRXSEC Form 4: Doyle Anthony was granted 115,000 shares, increasing direct ownership by 123% to 208,719 unitsForm 4Grant or award
- Nov 23, 2021+$440KBCRXSEC Form 4: Doyle Anthony bought $440,020 worth of shares (35,258 units at $12.48), increasing direct ownership by 60% to 93,719 unitsForm 4Open-market purchase
Compare Anthony Doyle with
- Anthony Doyle vs Jon P Stonehouse1 shared
- Anthony Doyle vs Jill C. Milne1 shared
- Anthony Doyle vs Vincent Milano1 shared
- Anthony Doyle vs Amy E McKee1 shared
- Anthony Doyle vs Steven Frank1 shared
- Anthony Doyle vs Steven K Galson1 shared
Other insiders at the same companies
- Jon P StonehouseBCRX
- Jill C. MilneBCRX
- Vincent MilanoBCRX
- Amy E McKeeBCRX
- Steven FrankBCRX
- Steven K GalsonBCRX
- Alan G LevinBCRX
- Machelle SandersBCRX
- Theresa HeggieBCRX
- Alane P BarnesBCRX
- Sandeep MenonBCRX
- Ronald DullingerBCRX
- Charles K GayerBCRX
- Babar GhiasBCRX
- Nancy J HutsonBCRX
- Helen M. ThackrayBCRX
Questions about Anthony Doyle
- What is Anthony Doyle's role at Biocryst Pharmaceuticals Inc?
- Anthony Doyle reports to the SEC as chief Financial Officer at Biocryst Pharmaceuticals Inc (BCRX), according to the latest filing on December 23, 2024.
- How many shares does Anthony Doyle own?
- After the latest filing that states it, Anthony Doyle directly owned 377,867 shares of Biocryst Pharmaceuticals Inc (BCRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Anthony Doyle bought or sold stock recently?
- The most recent open-market purchase was on May 14, 2024: bought 36,300 shares of Biocryst Pharmaceuticals Inc (BCRX) for $202K at an average of $5.57. The most recent open-market sale was on December 15, 2022: sold 5,700 shares of Biocryst Pharmaceuticals Inc (BCRX) for $62.1K at an average of $10.90.
- How do I get alerts when Anthony Doyle files?
- Follow Anthony Doyle on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Anthony Doyle (SEC CIK 0001808688). Totals count each trade once, skipping amendments whose original is on file, from Nov 24, 2021 on. View on SEC EDGAR · Get this as JSON